Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)
Martin W Hümmert,Carlotta Stern,Friedemann Paul,Ankelien Duchow,Judith Bellmann-Strobl,Ilya Ayzenberg,Carolin Schwake,Ingo Kleiter,Kerstin Hellwig,Sven Jarius,Brigitte Wildemann,Makbule Senel,Achim Berthele,Katrin Giglhuber,Felix Luessi,Matthias Grothe,Luisa Klotz,Rasmus Schülke,Stefan Gingele,Jürgen H Faiss,Annette Walter,Clemens Warnke,Florian Then Bergh,Orhan Aktas,Marius Ringelstein,Jan-Patrick Stellmann,Vivien Häußler,Joachim Havla,Hannah Pellkofer,Tania Kümpfel,Bruno Kopp,Corinna Trebst
DOI: https://doi.org/10.1177/13524585231151212
2023-02-16
Multiple Sclerosis
Abstract:Multiple Sclerosis Journal, Ahead of Print. Background:There is limited and inconsistent information on the prevalence of cognitive impairment in neuromyelitis optica spectrum disorders (NMOSD).Objective:To assess cognitive performance and changes over time in NMOSD.Methods:This study included data from 217 aquaporin-4-IgG-seropositive (80%) and double-seronegative NMOSD patients. Cognitive functions measured by Symbol Digit Modalities Test (SDMT), Paced Auditory Serial-Addition Task (PASAT), and/or Multiple Sclerosis Inventory Cognition (MuSIC) were standardized against normative data (N = 157). Intraindividual cognitive performance at 1- and 2-year follow-up was analyzed. Cognitive test scores were correlated with demographic and clinical variables and assessed with a multiple linear regression model.Results:NMOSD patients were impaired in SDMT (p = 0.007), MuSIC semantic fluency (p < 0.001), and MuSIC congruent speed (p < 0.001). No significant cognitive deterioration was found at follow-up. SDMT scores were related to motor and visual disability (pBon < 0.05). No differences were found between aquaporin-4-IgG-seropositive and double-seronegative NMOSD.Conclusions:A subset of NMOSD patients shows impairment in visual processing speed and in semantic fluency regardless of serostatus, without noticeable changes during a 2-year observation period. Neuropsychological measurements should be adapted to physical and visual disabilities.